Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Magaly Perez-Nieves, Samaneh Kabul, Urvi Desai, Jasmina I. Ivanova, Noam Y. Kirson, Alice Kate Cummings, Howard G. Birnbaum, Ran Duan, Dachuang Cao & Irene Hadjiyianni. (2016) Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US. Current Medical Research and Opinion 32:4, pages 669-680.
Read now
Read now
Ronald Goldenberg. (2014) Insulin plus incretin agent combination therapy in type 2 diabetes: a systematic review. Current Medical Research and Opinion 30:3, pages 431-445.
Read now
Read now
Michael Grabner, Yong Chen, Matthew Nguyen, Scott D Abbott & Ralph Quimbo. (2013) Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device. ClinicoEconomics and Outcomes Research 5, pages 471-479.
Read now
Read now
Articles from other publishers (21)
Roberto Farina, Rodrigo Lopez, Anna Simonelli & Leonardo Trombelli. (2023) Accuracy and applicability of periodontitis risk assessment tools: A critical appraisal. Periodontology 2000.
Crossref
Crossref
Kevin Cowart, Rachel Franks, Olivia Pane, Ellen Murphy & Kelly Oldziej. (2022) Addressing Overbasalization to Achieve Glycemic Targets. ADCES in Practice 10:2, pages 30-35.
Crossref
Crossref
Wenhuan Feng, Weimin Wang, Ran Meng, Guangyu Wu, Minlu Zhang, Xia Zhang, Huiqiu Yin & Dalong Zhu. (2021) Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies. BMJ Open Diabetes Research & Care 9:1, pages e002290.
Crossref
Crossref
Kalyan Kumar Gangopadhyay, Sujoy Majumdar, Binayak Sinha, Rajiv Kovil & Manash Pratim Baruah. (2020) IRWIS (IDegLira Real world Indian Study): A Real-World Observational Study For Use of IDegLira In Indian Patients. Endocrine and Metabolic Science 1:3-4, pages 100057.
Crossref
Crossref
Kevin Cowart. (2020) Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin. Clinical Diabetes 38:3, pages 304-310.
Crossref
Crossref
Puhong Zhang, Heng Zhang, Xian Li, Minyuan Chen, Du Wang & Linong Ji. (2020) Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus. Endocrinology, Diabetes & Metabolism 3:2.
Crossref
Crossref
David R. Owens, Wolfgang Landgraf, Brian M. Frier, Mei Zhang, Philip D. Home, Luigi Meneghini & Geremia B. Bolli. (2019) Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%. Diabetes, Obesity and Metabolism 21:2, pages 321-329.
Crossref
Crossref
Yu ZhuPuhong ZhangDongshan ZhuXian LiJiachao JiLinong Ji. (2018) Predictors of Glycemic Control in Patients with Type 2 Diabetes: A Subgroup Analysis of the Observational Registry of Basal Insulin Treatment Study in China. Diabetes Technology & Therapeutics 20:12, pages 825-832.
Crossref
Crossref
Lawrence Blonde, Luigi Meneghini, Xuejun Victor Peng, Anders Boss, Kyu Rhee, Alka Shaunik, Supriya Kumar, Sidhartha Balodi, Claire Brulle-Wohlhueter & Rory J. McCrimmon. (2018) Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA. Diabetes Therapy 9:3, pages 1347-1358.
Crossref
Crossref
Lori Berard, Mireille Bonnemaire, Marie Mical & Steve Edelman. (2017)
Insights into optimal basal insulin titration in type 2 diabetes:
R
esults of a quantitative survey
. Diabetes, Obesity and Metabolism 20:2, pages 301-308.
Crossref
Crossref
Yongming Qu, Junxiang Luo, Parag Garhyan, Caryl J. Antalis, Annette M. Chang & Scott J. Jacober. (2017) Dose Unit Establishment for a New Basal Insulin Using Joint Modeling of Insulin Dose and Glycemic Response. Journal of Diabetes Science and Technology 12:1, pages 155-162.
Crossref
Crossref
Dídac Mauricio, Luigi Meneghini, Jochen Seufert, Laura Liao, Hongwei Wang, Liyue Tong, Anna Cali, Peter Stella, Paulo Carita & Kamlesh Khunti. (2017) Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. Diabetes, Obesity and Metabolism 19:8, pages 1155-1164.
Crossref
Crossref
Virginia Valentine, Jennifer Goldman & Jay H. Shubrook. (2017) Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes. Diabetes Therapy 8:4, pages 739-752.
Crossref
Crossref
Ronan Roussel, Bernard Charbonnel, Mourad Behar, Julie Gourmelen, Corinne Emery & Bruno Detournay. (2016) Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study. Diabetes Therapy 7:3, pages 537-549.
Crossref
Crossref
H. W. Rodbard, J. B. Buse, V. Woo, T. Vilsbøll, I. H. Langbakke, K. Kvist & S. C. L. Gough. (2015) Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes. Diabetes, Obesity and Metabolism 18:1, pages 40-48.
Crossref
Crossref
Lizheng Shi, Xin Ye, Mei Lu, Eric Q. Wu, Hari Sharma, Darren Thomason, Mengxi Zhang, Yao Wang & Vivian A. Fonseca. (2015) Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study. Diabetes Therapy 6:3, pages 339-355.
Crossref
Crossref
Beverley Balkau, Françoise Calvi-Gries, Nick Freemantle, Maya Vincent, Valerie Pilorget & Philip D. Home. (2015) Predictors of HbA1c over 4 years in people with type 2 diabetes starting insulin therapies: The CREDIT study. Diabetes Research and Clinical Practice 108:3, pages 432-440.
Crossref
Crossref
Wenying Yang, Xiaoming Zhuang, Yukun Li, Qing Wang, Rongwen Bian, Jianguo Shen, Eva Hammerby & Li Yang. (2014) Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational study. Health and Quality of Life Outcomes 12:1.
Crossref
Crossref
Michael L Ganz, Neil Wintfeld, Qian Li, Veronica Alas, Jakob Langer & Mette Hammer. (2014) The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States. Diabetology & Metabolic Syndrome 6:1.
Crossref
Crossref
John B. Buse, Tina Vilsbøll, Jerry Thurman, Thomas C. Blevins, Irene H. Langbakke, Susanne G. Bøttcher & Helena W. Rodbard. (2014) Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira). Diabetes Care 37:11, pages 2926-2933.
Crossref
Crossref
Riccardo Perfetti. (2013) Comprehensive approach to the management of diabetes: offering improved outcomes for diabetics and the healthcare system. Diabetes Management 3:6, pages 505-528.
Crossref
Crossref